Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
343
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
+418K
-
Total reported value, excl. options
-
$6.39B
-
Value change
-
+$145M
-
Put/Call ratio
-
3.36
-
Number of buys
-
191
-
Number of sells
-
-121
-
Price
-
$332.74
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2019
386 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q3 2019.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 343 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
.
Largest 10 shareholders include BlackRock Inc. (2.1M shares), VANGUARD GROUP INC (1.92M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (753K shares), AMERICAN CENTURY COMPANIES INC (728K shares), WELLS FARGO & COMPANY/MN (671K shares), STATE STREET CORP (501K shares), FMR LLC (494K shares), MILLENNIUM MANAGEMENT LLC (471K shares), UBS ASSET MANAGEMENT AMERICAS INC (419K shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (412K shares).
This table shows the top 343 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.